| Expression and prognosis role of indoleamine 2, 3-dioxygenase in hepatocellular carcinoma K Pan, H Wang, M Chen, H Zhang, D Weng, J Zhou, W Huang, J Li, ... Journal of cancer research and clinical oncology 134, 1247-1253, 2008 | 210 | 2008 |
| Increased polycomb-group oncogene Bmi-1 expression correlates with poor prognosis in hepatocellular carcinoma H Wang, K Pan, H Zhang, D Weng, J Zhou, J Li, W Huang, H Song, ... Journal of cancer research and clinical oncology 134, 535-541, 2008 | 163 | 2008 |
| The accumulation and prognosis value of tumor infiltrating IL-17 producing cells in esophageal squamous cell carcinoma L Lv, K Pan, X Li, K She, J Zhao, W Wang, J Chen, Y Chen, J Yun, J Xia PloS one 6 (3), e18219, 2011 | 156 | 2011 |
| Intratumoral expression of IL-17 and its prognostic role in gastric adenocarcinoma patients J Chen, J Xia, X Liang, K Pan, W Wang, L Lv, J Zhao, Q Wang, Y Li, ... International journal of biological sciences 7 (1), 53, 2011 | 144 | 2011 |
| Comparative study on anti-tumor immune response of autologous cytokine-induced killer (CIK) cells, dendritic cells-CIK (DC-CIK), and semi-allogeneic DC-CIK QJ Wang, H Wang, K Pan, YQ Li, LX Huang, SP Chen, J He, ML Ke, ... Chin J Cancer 29 (7), 641-648, 2010 | 144 | 2010 |
| The prognostic value of tumor-infiltrating neutrophils in gastric adenocarcinoma after resection J Zhao, K Pan, W Wang, J Chen, Y Wu, L Lv, J Li, Y Chen, D Wang, Q Pan, ... PloS one 7 (3), e33655, 2012 | 141 | 2012 |
| Decreased Expression of the ARID1A Gene Is Associated with Poor Prognosis in Primary Gastric Cancer D Wang, Y Chen, K Pan, W Wang, S Chen, J Chen, J Zhao, L Lv, Q Pan, ... PloS one 7 (7), e40364, 2012 | 133 | 2012 |
| Interleukin-37 mediates the antitumor activity in hepatocellular carcinoma: role for CD57+ NK cells JJ Zhao, QZ Pan, K Pan, DS Weng, QJ Wang, JJ Li, L Lv, DD Wang, ... Scientific reports 4 (1), 5177, 2014 | 114 | 2014 |
| A phase I clinical trial utilizing autologous tumor-infiltrating lymphocytes in patients with primary hepatocellular carcinoma SS Jiang, Y Tang, YJ Zhang, DS Weng, ZG Zhou, K Pan, QZ Pan, ... Oncotarget 6 (38), 41339, 2015 | 111 | 2015 |
| Clinical activity of adjuvant cytokine-induced killer cell immunotherapy in patients with post-mastectomy triple-negative breast cancer K Pan, XX Guan, YQ Li, JJ Zhao, JJ Li, HJ Qiu, DS Weng, QJ Wang, Q Liu, ... Clinical Cancer Research 20 (11), 3003-3011, 2014 | 108 | 2014 |
| The efficacy of cytokine-induced killer cell infusion as an adjuvant therapy for postoperative hepatocellular carcinoma patients KE Pan, YQ Li, W Wang, L Xu, YJ Zhang, HX Zheng, JJ Zhao, HJ Qiu, ... Annals of surgical oncology 20, 4305-4311, 2013 | 99 | 2013 |
| IL-17A promotes immune cell recruitment in human esophageal cancers and the infiltrating dendritic cells represent a positive prognostic marker for patient survival L Lu, K Pan, HX Zheng, JJ Li, HJ Qiu, JJ Zhao, DS Weng, QZ Pan, ... Journal of immunotherapy 36 (8), 451-458, 2013 | 82 | 2013 |
| Autologous cytokine-induced killer cell transfusion in combination with gemcitabine plus cisplatin regimen chemotherapy for metastatic nasopharyngeal carcinoma J Li, M Gu, K Pan, L Liu, H Zhang, W Shen, J Xia Journal of immunotherapy 35 (2), 189-195, 2012 | 79 | 2012 |
| Galectin-3 is associated with a poor prognosis in primary hepatocellular carcinoma SS Jiang, DS Weng, QJ Wang, K Pan, YJ Zhang, YQ Li, JJ Li, JJ Zhao, ... Journal of translational medicine 12, 1-14, 2014 | 77 | 2014 |
| Annexin A3 as a potential target for immunotherapy of liver cancer stem-like cells QZ Pan, K Pan, QJ Wang, DS Weng, JJ Zhao, HX Zheng, XF Zhang, ... Stem Cells 33 (2), 354-366, 2015 | 76 | 2015 |
| Decreased expression of ING2 gene and its clinicopathological significance in hepatocellular carcinoma H Zhang, K Pan, H Wang, D Weng, H Song, J Zhou, W Huang, J Li, ... Cancer letters 261 (2), 183-192, 2008 | 74 | 2008 |
| Cytotoxic T lymphocyte antigen-4 expression in esophageal carcinoma: implications for prognosis XF Zhang, KE Pan, DS Weng, CL Chen, QJ Wang, JJ Zhao, QZ Pan, Q Liu, ... Oncotarget 7 (18), 26670, 2016 | 70 | 2016 |
| PD-L1 expression as a predictive biomarker for cytokine-induced killer cell immunotherapy in patients with hepatocellular carcinoma CL Chen, QZ Pan, JJ Zhao, Y Wang, YQ Li, QJ Wang, K Pan, DS Weng, ... Oncoimmunology 5 (7), e1176653, 2016 | 68 | 2016 |
| The clinical significance of preoperative serum cholesterol and high-density lipoprotein-cholesterol levels in hepatocellular carcinoma SS Jiang, DS Weng, L Jiang, YJ Zhang, K Pan, QZ Pan, CL Chen, ... Journal of Cancer 7 (6), 626, 2016 | 66 | 2016 |
| Annexin A3 promotes tumorigenesis and resistance to chemotherapy in hepatocellular carcinoma QZ Pan, K Pan, DS Weng, JJ Zhao, XF Zhang, DD Wang, L Lv, SS Jiang, ... Molecular carcinogenesis 54 (8), 598-607, 2015 | 64 | 2015 |
